20 LATEST RESOURCES (76 INDEXED)
Antidepressant Mechanisms of Ketamine: A Review of Actions with Relevance to Treatment-Resistance and Neuroprogression · August 2023
Articles
Frontiers in Neuroscience
Infant Exposure to Fluvoxamine through Placenta and Human Milk: A Case Series – A Contribution from the ConcePTION Project · May 2023
Articles
Frontiers in Psychiatry
Does Drug Use Affect the Efficacy of Amisulpride, Aripiprazole and Olanzapine in Patients with Schizophrenia Spectrum Disorders? Results from a Pragmatic, Randomised Study · May 2023
Articles
General Hospital Psychiatry
Interpersonal Psychotherapy versus Sertraline for Women with Posttraumatic Stress Disorder Following Recent Sexual Assault: A Randomized Clinical Trial · October 2022
Articles
European Journal of Psychotraumatology
Risks and Overdose Responses: Participant Characteristics from the First Seven Years of a National Take-Home Naloxone Program · September 2022
Articles
Drug and Alcohol Dependence
Metabolite Profiling of Clozapine in Patients Switching versus Maintaining Treatment: A Retrospective Pilot Study · September 2022
Articles
Journal of Clinical Psychopharmacology
Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norway · July 2022
Articles
Drugs-Real World Outcomes
Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients with Schizophrenia · January 2022
Abstracts
Journal of Clinical Psychopharmacology
‘Not at All What I Had Expected’: Discontinuing Treatment with Extended-Release Naltrexone (XR-NTX): A Qualitative Study · November 2021
Articles
Journal of Substance Abuse Treatment
Life Satisfaction among Individuals with Opioid Use Disorder Receiving Extended-Release Naltrexone: A 12-Week Randomized Controlled Trial and a 36-Week Follow-Up · November 2021
Abstracts
Journal of Substance Abuse Treatment
Risk of Relapse among Opioid-Dependent Patients Treated with Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial · September 2021
Articles
American Journal on Addictions
Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients · August 2021
Articles
CNS Drugs
The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Psychosis · August 2021
Abstracts
Substance Use and Misuse
Dentist-Administered Cognitive Behavioural Therapy versus Four Habits/Midazolam: An RCT Study of Dental Anxiety Treatment in Primary Dental Care · May 2021
Articles
European Journal of Oral Sciences
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib · February 2021
Articles
International Journal of Molecular Sciences
Adapting Treatment Length to Opioid-Dependent Individuals’ Needs and Preferences: A 2-Year Follow-Up to a 1-Year Study of Extended-Release Naltrexone · December 2020
Articles
Addiction
Amisulpride, Aripiprazole, and Olanzapine in Patients with Schizophrenia-Spectrum Disorders (BeSt InTro): A Pragmatic, Rater-Blind, Semi-Randomised Trial · October 2020
Abstracts
Lancet Psychiatry
The Association between Lithium Use and Neurocognitive Performance in Patients with Bipolar Disorder · April 2020
Articles
Neuropsychopharmacology
Exploring Lithium’s Transcriptional Mechanisms of Action in Bipolar Disorder: A Multi-Step Study · October 2019
Articles
Neuropsychopharmacology
Quality of Warfarin Therapy and Quality of Life Are Improved by Self-Management for Two Years · August 2019
Articles
Thrombosis and Haemostasis